NCT04293328

Brief Summary

The two-year prospective study aims at investigating frequently replacement effect on myopia control in young children, and the use of weekly protein removal system in monthly replacement modality orthokeratology lenses on surface deposit.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 29, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 3, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

July 7, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

2.9 years

First QC Date

February 29, 2020

Last Update Submit

July 18, 2022

Conditions

Keywords

Myopia progressionOrthokeratologyReplacement modalitySurface deposits

Outcome Measures

Primary Outcomes (2)

  • Axial elongation in 2 years

    Elongation of the eyeball in 24 months

    12 months

  • Changes in Back Surface Lens Deposits

    Surface deposits will be graded using a 4-point scale: 0=no deposit; 1=mild; 2=moderate; 3=severe

    Every month up to 24 months

Secondary Outcomes (1)

  • Number of participants with serious adverse effects in 2 years

    24 months

Study Arms (2)

Monthly replacement lenses without protein removal

EXPERIMENTAL

Subjects will be required to perform daily cleaning for the monthly replacement orthokeratology lenses

Device: orthokeratology

Monthly replacement lenses with weekly protein removal

ACTIVE COMPARATOR

Subjects will be required to perform both daily cleaning and weekly protein removal for the monthly replacement orthokeratology lenses

Device: orthokeratologyDevice: Menicon Progent A+B

Interventions

Nightly wear of orthokeratology lenses to correct vision in the daytime

Also known as: ortho-k, Menicon Z Night lenses, Menicon Z Night Toric lenses, corneal reshaping therapy
Monthly replacement lenses with weekly protein removalMonthly replacement lenses without protein removal

Menicon Progent A+B is a commercially available protein remover for rigid lenses. It has received FDA clearance and been launched in Hong Kong for over a decade. The product contains two separate sterile solutions, one with sodium hypochlorite and the other with potassium bromide. By mixing the two solutions in a special vial, it can clean and remove protein deposits on the lenses. Parents of subjects assigned to use weekly protein remover will be required to soak the cleansed lenses in the solution mixture for not more than 30 mins every week. All lenses must be rinsed thoroughly with saline and cleansed with daily cleaner again before daily disinfection.

Also known as: Menicon Progent Protein Remover for Rigid Gas Permeable Contact Lenses
Monthly replacement lenses with weekly protein removal

Eligibility Criteria

Age6 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Aged 6-10 years
  • Normal ocular and general condition and not on medication which may contraindicate ortho-k lens wear
  • Refractive sphere between -0.75 to -4.00 D, refractive cylinder ≤ -1.50 D and anisometropia ≤ -1.00 D
  • Best correctable vision better than 0.08 logMAR in the worse eye
  • Normal binocular function and accommodative status
  • No prior experience in contact lens wear and myopia control treatment

You may not qualify if:

  • Strabismus at distance or near
  • Contraindication for ortho-k lens wear
  • Prior history of ocular surgery, trauma, or chronic ocular disease
  • Systemic or ocular conditions that may interfere refractive development
  • Systemic or ocular conditions that may interfere tear quality and contact lens wear
  • Poor response to the use of study lenses
  • Poor compliance to test procedures
  • Poor compliance to the use of ortho-k lenses (e.g. use of solution, use of lenses)
  • Poor compliance to follow-up schedule

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Optometry, The Hong Kong Polytechnic University

Kowloon, Hong Kong

Location

Related Publications (5)

  • Lee YC, Wang JH, Chiu CJ. Effect of Orthokeratology on myopia progression: twelve-year results of a retrospective cohort study. BMC Ophthalmol. 2017 Dec 8;17(1):243. doi: 10.1186/s12886-017-0639-4.

    PMID: 29216865BACKGROUND
  • Stapleton F, Carnt N. Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis. Eye (Lond). 2012 Feb;26(2):185-93. doi: 10.1038/eye.2011.288. Epub 2011 Dec 2.

    PMID: 22134592BACKGROUND
  • Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7077-85. doi: 10.1167/iovs.12-10565.

    PMID: 22969068BACKGROUND
  • Hiraoka T, Kakita T, Okamoto F, Takahashi H, Oshika T. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012 Jun 22;53(7):3913-9. doi: 10.1167/iovs.11-8453.

    PMID: 22577080BACKGROUND
  • Cheung SW, Boost MV, Cho P. Pre-treatment observation of axial elongation for evidence-based selection of children in Hong Kong for myopia control. Cont Lens Anterior Eye. 2019 Aug;42(4):392-398. doi: 10.1016/j.clae.2018.10.006. Epub 2018 Oct 24.

    PMID: 30366778BACKGROUND

Study Officials

  • Pauline Cho, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Independent examiners will be responsible for the assessment of the primary outcomes, which are the axial length and surface coating.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: All subjects will be prescribed with monthly replacement orthokeratology for a period of 12 months. They will be randomly assigned to normal cleaning and intensive cleaning groups on 1:1 basis. All subjects follow the same daily cleaning procedures and subjects in intensive cleaning group will be required to perform weekly protein removal in addition to the daily routine.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 29, 2020

First Posted

March 3, 2020

Study Start

July 7, 2020

Primary Completion

June 1, 2023

Study Completion

August 1, 2023

Last Updated

July 20, 2022

Record last verified: 2022-07

Locations